Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2971 AL 2985

Design optimization for clinical trials in early-stage manifest Huntington's disease

Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C; TRACK-HD Investigators.

Mov Disord. 2017 Nov;32(11):1610-1619. doi: 10.1002/mds.27122. Epub 2017 Sep 14.

Using Genome Engineering to Understand Huntington’s Disease

Bailus B, Zhang N, Ellerby LM.

2017 Sep 15. In: Jaenisch R, Zhang F, Gage F, editors. Genome Editing in Neurosciences [Internet]. Cham (CH): Springer; 2017.

Genome-Wide Genetic Screening in the Mammalian CNS

Wertz MH, Heiman M.

2017 Sep 15. In: Jaenisch R, Zhang F, Gage F, editors. Genome Editing in Neurosciences [Internet]. Cham (CH): Springer; 2017.

Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases

Ciregia F, Urbani A, Palmisano G.

Front Mol Neurosci. 2017 Aug 31;10:276. doi: 10.3389/fnmol.2017.00276. eCollection 2017.

Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases

Weng TY, Tsai SA, Su TP.

J Biomed Sci. 2017 Sep 16;24(1):74. doi: 10.1186/s12929-017-0380-6.

Therapies targeting DNA and RNA in Huntington's disease

Wild EJ, Tabrizi SJ.

Lancet Neurol. 2017 Oct;16(10):837-847. doi: 10.1016/S1474-4422(17)30280-6. Epub 2017 Sep 12.

The heat shock response in neurons and astroglia and its role in neurodegenerative diseases

San Gil R, Ooi L, Yerbury JJ, Ecroyd H.

Mol Neurodegener. 2017 Sep 18;12(1):65. doi: 10.1186/s13024-017-0208-6.

Globular glial tauopathy presenting as non-fluent/agrammatic variant primary progressive aphasia with chorea

Kim EJ, Lee MJ, Lee JH, Lee YM, Shin JH, Shin MJ, Choi KU, Jung NY, Pak K, Hwang C, Ahn JW, Sung S, Spina S, Grinberg LT, Seeley WW, Huh GY.

Parkinsonism Relat Disord. 2017 Nov;44:159-161. doi: 10.1016/j.parkreldis.2017.09.006. Epub 2017 Sep 6.

Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases

Moloudizargari M, Asghari MH, Ghobadi E, Fallah M, Rasouli S, Abdollahi M.

Ageing Res Rev. 2017 Nov;40:64-74. doi: 10.1016/j.arr.2017.09.005. Epub 2017 Sep 18.

Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease

Bellosta Diago E, Pérez Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez Horta S, Kulisevsky J, López Del Val J.

Parkinsonism Relat Disord. 2017 Nov;44:95-100. doi: 10.1016/j.parkreldis.2017.09.013. Epub 2017 Sep 15.

Preimplantation genetics and other reproductive options in Huntington disease

Blancato JK, Wolfe EM, Sacks PC.

Handb Clin Neurol. 2017;144:107-111. doi: 10.1016/B978-0-12-801893-4.00009-2.

Genetic testing for Huntington disease

Quaid KA.

Handb Clin Neurol. 2017;144:113-126. doi: 10.1016/B978-0-12-801893-4.00010-9.

Medical treatment of behavioral manifestations of Huntington disease

van Duijn E.

Handb Clin Neurol. 2017;144:129-139. doi: 10.1016/B978-0-12-801893-4.00011-0.

Medical management of motor manifestations of Huntington disease

McCusker EA, Loy CT.

Handb Clin Neurol. 2017;144:141-150. doi: 10.1016/B978-0-12-801893-4.00012-2.

Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapies

Ross CA, Kronenbuerger M, Duan W, Margolis RL.

Handb Clin Neurol. 2017;144:15-28. doi: 10.1016/B978-0-12-801893-4.00002-X.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias